Clinical Trial

Clinical Predictors of Visual Outcome in Patients Affected With Ocular Surface Diseases

Study acronym: OSD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This retrospective-prospective study aims to identify the diagnostic parameters most predictive of BSCVA in patients with OSD. Clinical, structural, and biochemical data will be collected from standard-of-care examinations and patient-reported outcome questionnaires. The goal is to determine the most informative biomarkers for visual prognosis, streamline diagnostic workflows, and support individualized management of OSD.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-04.
Trial Details
NCT Number NCT07694817
Lead Sponsor IRCCS San Raffaele
Conditions Neurotrophic Keratopathy, Exposure Keratopathy, Limbal Stem Cell Deficiency (LSCD), Cornea Abnormality, Cornea Disease, Cornea Inflamed
Enrollment 1,000 participants
Start Date 2026-07
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-14